Company & Sponsor Intelligence

University of Maryland, Baltimore

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials12

Recruiting1

Completed9

Countries1

Therapeutic footprint

autismbipolar_disorderdepressionepilepsyother_neurologypain_neuropathyptsdschizophreniastroke

Indexed studies

NCT01433055Adjunctive Minocycline in Clozapine Treated Schizophrenia Patients
schizophrenia · United StatesNA

NCT00746252Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar Disorder
bipolar_disorder · United StatesNA

NCT00742365Predicting Effectiveness of Light Treatment for Winter Seasonal Affective Disorder
depression · COMPLETED

NCT02657772Ultra Coils From Start to Finish for the Endovascular Repair of Small Intracranial Aneurysms
other_neurology · United StatesCOMPLETED

NCT01754610Strengthening Family Coping Resources Open Trials
ptsd · United StatesCOMPLETED

NCT00554840Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia
schizophrenia · PHASE2

NCT04313283Translating Peer-to-Peer Support Into a Clinical Setting
autism · United StatesNA

NCT07532564Risk Factors, Costs, and Impacts of ED Boarding
stroke · United StatesCOMPLETED

NCT04241562Validation of a Novel Cortical Biomarker Signature for Pain
pain_neuropathy · United StatesCOMPLETED

NCT01995825Lamotrigine Bioequivalence
epilepsy · United StatesPHASE4

NCT02369770Sensory-Motor Rehabilitation Post Stroke
stroke · United StatesNA

NCT03300128Incredible Years Program for Parents of Children with Autism
autism · United StatesNA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →